Articles by Eric Langer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Eric Langer

Offshoring Biomanufacturing

Will international biomanufacturing outsourcing become mainstream in this decade?
Jan 1, 2013

Will international biomanufacturing outsourcing become mainstream in this decade?

Gauging Biopharm Outsourcing

Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.
Sep 5, 2012

Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.

Gauging Biopharm Outsourcing

Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.
Aug 2, 2012

Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.

Biomanufacturing Innovation

Industry wants more innovation, but can suppliers meet customer needs?
Jul 11, 2012

Industry wants more innovation, but can suppliers meet customer needs?

Biomanufacturing Innovation

Industry wants more innovation, but can suppliers meet customer needs?
Jun 2, 2012

Industry wants more innovation, but can suppliers meet customer needs?

Biomanufacturing Innovation

The industry wants more innovation, but can suppliers meet customers' needs?
Jun 1, 2012

The industry wants more innovation, but can suppliers meet customers' needs?

Biomanufacturing Outlook

Industry optimism is on the rise for 2012.
Mar 7, 2012

Industry optimism is on the rise for 2012.

Biomanufacturing Outlook

Industry optimism is on the rise for 2012.
Feb 2, 2012

Industry optimism is on the rise for 2012.

Biosimilars' Technology Needs

Biosimilar manufacturers need better expression systems and analytical tools to compete.
Dec 7, 2011

Biosimilar manufacturers need better expression systems and analytical tools to compete.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here